BIOMAT Database Logo BIOMAT Database Logo

[Antibacterial activity in vitro of ristocetin, kanamycin and farmiglucine]. 1964

L Pierangeli, and A Vellucci, and G Tallarida, and G Donati

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin

Related Publications

L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[Antibacterial activity of ristocetin].
November 1958, La Riforma medica,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[Bactericidal activity in vitro of vancomycin, ristocetin and kanamycin on Micrococcus pyogenes var. aureus].
January 1960, Nuovi annali d'igiene e microbiologia,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
Antibacterial activity of Kanamycin.
March 1958, Antibiotics & chemotherapy (Northfield, Ill.),
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[THE ANTIBACTERIAL ACTION OF KANAMYCIN IN VITRO AND ITS CHEMOTHERAPEUTIC ACTIVITY].
February 1964, Antibiotiki,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[Activity in vitro of vancomycin, ristocetin and kanamycin on 85 strains of M. pyogenes var. aureus].
January 1960, Nuovi annali d'igiene e microbiologia,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[Antibacterial activity in vitro and in vivo of a new kanamycin: BBK-8].
January 1974, Antibiotica,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[Kanamycin: study of its antibacterial activity].
April 1959, La Riforma medica,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[Antibacterial activity of ristocetin in combination with various antibiotics].
March 1959, La Clinica terapeutica,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
Calcium inhibition of antibacterial activity of kanamycin.
August 1972, American journal of veterinary research,
L Pierangeli, and A Vellucci, and G Tallarida, and G Donati
[On the "in vitro" action of vancomycin, of ristocetin and of kanamycin on pathogenic strains of staphylococci].
January 1959, Strasbourg medical,
Copied contents to your clipboard!